Asian Phytoceuticals Public Company Limited Net Assets
Asian Phytoceuticals Public Company Limited net assets. Based on the latest financial reports, Asian Phytoceuticals Public Company Limited (APCO) has net assets worth ฿578.81 Million THB (≈ $18.04 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿648.72 Million ≈ $20.22 Million USD) and total liabilities (฿69.91 Million ≈ $2.18 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore APCO net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿578.81 Million |
| % of Total Assets | 89.22% |
| Annual Growth Rate | 8.85% |
| 5-Year Change | -5.85% |
| 10-Year Change | -13.7% |
| Growth Volatility | 23.55 |
Net Assets of Asian Phytoceuticals Public Company Limited (2007–2025)
Net assets of Asian Phytoceuticals Public Company Limited from 2007 to 2025. This chart illustrates how Asian Phytoceuticals Public Company Limited's net assets have evolved over time, based on quarterly financial data. See Asian Phytoceuticals Public Company Limi (APCO) net asset quality to measure how much of total assets are equity-financed.
Annual Net Assets for Asian Phytoceuticals Public Company Limited (2007–2025)
The table below shows the annual net assets of Asian Phytoceuticals Public Company Limited from 2007 to 2025. For live market cap and overall valuation, see Asian Phytoceuticals Public Company Limi (APCO) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ฿560.19 Million ≈ $17.46 Million |
+0.08% |
| 2024-12-31 | ฿559.72 Million ≈ $17.45 Million |
-8.60% |
| 2023-12-31 | ฿612.39 Million ≈ $19.09 Million |
+0.31% |
| 2022-12-31 | ฿610.51 Million ≈ $19.03 Million |
+2.61% |
| 2021-12-31 | ฿594.99 Million ≈ $18.55 Million |
-0.08% |
| 2020-12-31 | ฿595.46 Million ≈ $18.56 Million |
+2.81% |
| 2019-12-31 | ฿579.19 Million ≈ $18.05 Million |
-5.69% |
| 2018-12-31 | ฿614.16 Million ≈ $19.14 Million |
-2.25% |
| 2017-12-31 | ฿628.31 Million ≈ $19.58 Million |
-3.20% |
| 2016-12-31 | ฿649.10 Million ≈ $20.23 Million |
+14.24% |
| 2015-12-31 | ฿568.18 Million ≈ $17.71 Million |
+10.32% |
| 2014-12-31 | ฿515.04 Million ≈ $16.05 Million |
+27.40% |
| 2013-12-31 | ฿404.28 Million ≈ $12.60 Million |
+7.14% |
| 2012-12-31 | ฿377.34 Million ≈ $11.76 Million |
+1.54% |
| 2011-12-31 | ฿371.61 Million ≈ $11.58 Million |
+99.87% |
| 2010-12-31 | ฿185.93 Million ≈ $5.80 Million |
+7.30% |
| 2009-12-31 | ฿173.29 Million ≈ $5.40 Million |
+22.20% |
| 2008-12-31 | ฿141.80 Million ≈ $4.42 Million |
+16.49% |
| 2007-12-31 | ฿121.73 Million ≈ $3.79 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Asian Phytoceuticals Public Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 888.8% over the analyzed period, indicating profitable operations and earnings retention.
Asian Phytoceuticals Public Company Limited Net Assets Breakdown (December 2025)
Asian Phytoceuticals Public Company Limited net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ฿79.31 Million | 14.24% |
| Common Stock | ฿300.00 Million | 53.86% |
| Other Comprehensive Income | ฿10.71 Million | 1.92% |
| Other Components | ฿166.94 Million | 29.97% |
| Total Equity | ฿556.96 Million | 100.00% |
Asian Phytoceuticals Public Company Limited Competitors by Market Cap
The table below lists competitors of Asian Phytoceuticals Public Company Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Euro Sun Mining Inc
TO:ESM
|
$46.40 Million |
|
ADAMA Ltd B
SHE:200553
|
$46.40 Million |
|
Lida Holdings Ltd
TW:4552
|
$46.41 Million |
|
ATrack Technology
TWO:6465
|
$46.42 Million |
|
Bluemount Holdings Limited Class B Ordinary Shares
NASDAQ:BMHL
|
$46.35 Million |
|
Do Day Dream Public Company Limited
BK:DDD
|
$46.35 Million |
|
Instil Bio Inc.
NASDAQ:TIL
|
$46.32 Million |
|
Roundtop Machinery Industries Co Ltd
TW:1540
|
$46.32 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Asian Phytoceuticals Public Company Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 556,823,023 to 556,961,609, a change of 138,586 (0.0%).
- Net income of 55,412,575 contributed positively to equity growth.
- Dividend payments of 55,163,347 reduced retained earnings.
- Other comprehensive income decreased equity by 19,292,887.
- Other factors increased equity by 19,182,245.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿55.41 Million | +9.95% |
| Dividends Paid | ฿55.16 Million | -9.9% |
| Other Comprehensive Income | ฿-19.29 Million | -3.46% |
| Other Changes | ฿19.18 Million | +3.44% |
| Total Change | ฿- | 0.02% |
Book Value vs Market Value Analysis
This analysis compares Asian Phytoceuticals Public Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.67x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.98x to 2.67x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | ฿0.83 | ฿2.48 | x |
| 2011-12-31 | ฿1.24 | ฿2.48 | x |
| 2012-12-31 | ฿0.80 | ฿2.48 | x |
| 2013-12-31 | ฿0.73 | ฿2.48 | x |
| 2014-12-31 | ฿0.10 | ฿2.48 | x |
| 2015-12-31 | ฿1.04 | ฿2.48 | x |
| 2016-12-31 | ฿1.17 | ฿2.48 | x |
| 2017-12-31 | ฿1.05 | ฿2.48 | x |
| 2018-12-31 | ฿1.02 | ฿2.48 | x |
| 2019-12-31 | ฿0.97 | ฿2.48 | x |
| 2020-12-31 | ฿0.99 | ฿2.48 | x |
| 2021-12-31 | ฿0.99 | ฿2.48 | x |
| 2022-12-31 | ฿1.01 | ฿2.48 | x |
| 2023-12-31 | ฿1.02 | ฿2.48 | x |
| 2024-12-31 | ฿0.93 | ฿2.48 | x |
| 2025-12-31 | ฿0.93 | ฿2.48 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Asian Phytoceuticals Public Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.95%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 27.68%
- • Asset Turnover: 0.32x
- • Equity Multiplier: 1.13x
- Recent ROE (9.95%) is below the historical average (16.38%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 14.16% | 14.30% | 0.82x | 1.21x | ฿5.89 Million |
| 2009 | 31.40% | 18.72% | 1.29x | 1.30x | ฿37.08 Million |
| 2010 | 23.81% | 17.31% | 1.18x | 1.17x | ฿25.67 Million |
| 2011 | 13.50% | 17.25% | 0.71x | 1.10x | ฿13.00 Million |
| 2012 | 14.77% | 19.49% | 0.68x | 1.12x | ฿18.00 Million |
| 2013 | 19.50% | 22.62% | 0.76x | 1.13x | ฿38.42 Million |
| 2014 | 23.06% | 27.89% | 0.76x | 1.09x | ฿67.26 Million |
| 2015 | 17.71% | 24.59% | 0.65x | 1.11x | ฿43.80 Million |
| 2016 | 20.25% | 31.19% | 0.59x | 1.10x | ฿66.51 Million |
| 2017 | 17.22% | 26.03% | 0.61x | 1.08x | ฿45.38 Million |
| 2018 | 15.43% | 25.62% | 0.56x | 1.08x | ฿33.33 Million |
| 2019 | 10.00% | 23.38% | 0.39x | 1.09x | ฿-14.93K |
| 2020 | 11.75% | 28.25% | 0.36x | 1.17x | ฿10.43 Million |
| 2021 | 11.55% | 30.76% | 0.33x | 1.14x | ฿9.20 Million |
| 2022 | 13.31% | 32.32% | 0.37x | 1.12x | ฿20.12 Million |
| 2023 | 17.63% | 36.72% | 0.42x | 1.16x | ฿46.52 Million |
| 2024 | 9.83% | 25.95% | 0.33x | 1.14x | ฿-971.41K |
| 2025 | 9.95% | 27.68% | 0.32x | 1.13x | ฿-283.59K |
Industry Comparison
This section compares Asian Phytoceuticals Public Company Limited's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,296,969,798
- Average return on equity (ROE) among peers: 14.77%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Asian Phytoceuticals Public Company Limited (APCO) | ฿578.81 Million | 14.16% | 0.12x | $46.38 Million |
| Do Day Dream Public Company Limited (DDD) | $4.57 Billion | 0.53% | 0.08x | $46.35 Million |
| Jack Chia Industries (Thailand) Public Company Limited (JCT) | $541.31 Million | 13.67% | 0.09x | $35.35 Million |
| Karmarts Public Company Limited (KAMART) | $551.60 Million | 35.92% | 0.27x | $257.99 Million |
| Moong Pattana International Public Company Limited (MOONG) | $793.77 Million | 7.20% | 0.26x | $23.41 Million |
| O.C.C. Public Company Limited (OCC) | $809.01 Million | 10.24% | 0.34x | $18.14 Million |
| Thai Nippon Rubber Industry Public Co. Ltd (TNR) | $516.04 Million | 21.04% | 1.32x | $54.70 Million |
About Asian Phytoceuticals Public Company Limited
Asian Phytoceuticals Public Company Limited engages in the research and development, manufacture, and distribution of healthcare and natural extracts-based beauty products in Thailand. The company offers cream and lotion products in bottles and tubes for massage to tighten the skin and reduce the desired area, and facial lotion products; and products for reverse aging, anti-aging, and longevity. … Read more